Atrial Fibrillation Trial, Recruiting (NCT05996159)

Atrial Fibrillation Trial, Recruiting NCT05996159 Sponsor: Seoul National University Hospital Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT05996159 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a type of irregular heartbeat called paroxysmal atrial fibrillation (AF that comes and goes) and are scheduled to have a specific heart procedure called pulmonary vein isolation (a procedure to treat this irregular heartbeat)

Who may not be able to join:

You are younger than 19 years old
Your atrial fibrillation is persistent (meaning it does not stop on its own)
You have previously had a procedure or surgery to treat atrial fibrillation
You have had a blood clot in your heart, or a stroke or blood clot-related event, within the last 90 days
You have had heart surgery or a heart attack within the last 90 days
You cannot take blood-thinning medications for any reason
A specific measurement of one of your heart chambers (the left atrium) is larger than 55 mm (confirm with trial site)
Your heart's pumping strength is below a certain level (less than 35% of normal capacity)
You are pregnant or planning to become pregnant during the study
You have a life expectancy of less than one year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eue-Keun Choi, M.D. Ph.D., Seoul National University Hospital

Phone: 82-2-2072-0688

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05996159

Sponsor: Seoul National University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 82-2-2072-0688

More information: https://clinicaltrials.gov/study/NCT05996159

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a type of irregular heartbeat called paroxysmal atrial fibrillation (AF that comes and goes) and are scheduled to have a specific heart procedure called pulmonary vein isolation (a procedure to treat this irregular heartbeat)

Who may not be able to join:

You are younger than 19 years old
Your atrial fibrillation is persistent (meaning it does not stop on its own)
You have previously had a procedure or surgery to treat atrial fibrillation
You have had a blood clot in your heart, or a stroke or blood clot-related event, within the last 90 days
You have had heart surgery or a heart attack within the last 90 days
You cannot take blood-thinning medications for any reason
A specific measurement of one of your heart chambers (the left atrium) is larger than 55 mm (confirm with trial site)
Your heart's pumping strength is below a certain level (less than 35% of normal capacity)
You are pregnant or planning to become pregnant during the study
You have a life expectancy of less than one year

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Seoul National University Hospital

Registry

ClinicalTrials.gov

Start date

7 November 2023

Est. completion

30 July 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Time for AF ablation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov